Member Info for belgrano

Hi Mathurin,
Believe a lot of the investigations are still in its infancy as per the latest RNS. Good to see the company has strong pipeline of products coming along.
The microbiome, which is known to be linked with the inflammatory process, its activation and control pathways, offers a potential route to supporting the natural immune inflammatory response within products such as sunscreens. In February 2019, the US FDA issued guidance to remove two common ingredients from cosmetics and sunscreens (aminobenzoic acid and trolamine salicylate), and is in the process of evaluating further safety data on 12 other widely used ingredients, with many of the chemicals detected on the skin and in blood weeks after application1, 2. This has created a need within the sunscreen and cosmetics industries for more naturally derived ingredients that could support the body's immune inflammatory response to different environmental challenges.

Working with the translational dermatology team at Manchester University, SkinBioTherapeutics has already identified a number of inflammatory pathways of interest, and routes to target these pathways with microbiome-derived regulators. Subject to a positive programme outcome, the Company intends to pursue commercialisation of any identified bacterial formulations through their addition to existing third party products or the development of new products targeted at specific conditions.

Stuart Ashman, CEO of SkinBioTherapeutics, said:

"This research programme with the University of Manchester aims to widen our understanding of the role that the microbiome plays within the immune system, and how it can be used to support the body's natural immune response. Similarly to our approach with the AxisBiotix food supplement, we hope to eventually bring immune-supporting microbiome formulations to market through everyday products, such as skin lotions and creams, where we see an increasing consumer preference for natural ingredients. This is an exciting new area of research for us and has the potential to broaden our skin health pipeline further."

Prof Cath O'Neill, CSO of SkinBioTherapeutics said:

"There is now an extensive growing body of research demonstrating direct links between the microbiome and the immune system, and consequently skin health. The Company is in the middle of a food supplement study and the potential modifying effect on skin conditions, such as psoriasis. However, with this new line of research, we have the opportunity to assess the powerful effect of the microbiome on the immune system and skin health."

Hi Nick,
N.P. We all start somewhere as did I, 30 years ago..and plenty of errors and mistakes along the way. Its deliberate miss-leading of info from various companies and the CEO's that really make me grind my teeth, and have cause my biggest losses over many years. Sometimes I missed the warning signs which are nearly always there if you really look hard enough, so error was really mine. On the flip side many many cracking gains as well, and enjoyed chatting to fellow investors during the period. You do get a good "feel " after a while, so sometimes if you wait the the "official" report, a lot of opportunity is lost. However thats investing and some might say gambling, but with plenty of research you can make sure you load a lot of table numbers. However always the chance of the wheel coming up Zero, or be hit by factors outside the companies control, as many have found out in the last year for example.

Hi Nick,
There is no public information available. Also nothing official. Those participating have signed a NDA which is why some over exuberant posts from participants were removed. Officially we await the company to release its reports in about a month. First starters on the study have now finished their treatment and are on the cooling off period.
In anticipation of your next question I'd rather converse privately, However only if you agree to join in the naked Conga dance down the street when the customer base hits 500K, perhaps at the end of the "SBTX shareholders party". Think we may get a few takers for a good beer up.

I don't think it's a gamble at all, and why it's a study not a trial. There might be some really thick icing on the cake when the results are officially announced. That will be the effects on sufferers with different skin complaints that are also participating in the study. Have heard of two other conditions that have already improved. This is why I'm still buying stock and is already my largest holding. However nothing official yet, and we await that confirmation. I want to see the study results coupled with short timeline to market, and perhaps some data showing study participants have signed up to the ongoing treatment as first customers. Throw in some data about benifical effects of other diseases, and that will see us to 1.50. crack the initial planned 25k customers and that's good for a couple of quid. Start ramping that customer base towards 500k that Stuart actually mentioned, and I'll join you dancing naked down the street.

yes Ted,
I suspect you are right a single investor and probably a individual is offloading the larger chunks. Not that there is anything wrong with that, we all have our own choices to make, and top slicing in my opinion is a good strategy.

Those that started first on the study may have already finished their last dose today, just the 14 day wait to check the time line of re-occurrence of symptoms to come. So in effect finished taking the treatment.
Stuart will already have a very clear picture of the results already, and I expect those that have finished taking with good results will be asking already for more treatment to prevent the psoriasis conditions returning. Be good to hear the answer.

Hi Ted,
Believe it momentum traders exiting with their pennies, we saw the same thing sub 50p. Market signals were plain to read for every trader. Actually good to see liquidity returning, knowing short termers are exiting.
Was expected and its a good thing.

Congratulations to all the investors here, not often we get to see moments like these. I do expect to see a raft of profit taking before very long, however this story is only just starting to unfold. Believe high possibility that profit taking will be bought into.
Clearly last and third resistance point has been broken, and now clear blue.
Your gains are fully deserved, think everyone should run the slide rule just over the initial 25k subscriptions at £1 a day that Stuart is talking about...then moving to 500K a day, at profit north of 50% per dose. Thats where the multibaggers will really lie.

"she's going blow captain".

Hi Robbie, havnt seen the latest ones if someone could quietly forward, much appreciated. pill taking finished in a couple of days anyway.

hi Bobbust,
Guess it depends on our definition of value. I believe the parent company will continue to increase sales, but could still still a while before it has high revenue returns, but with multi global contracts signed, dont think you will lose money from the current price. Indeed if SBTX does very well OPTI could do good, by just contining at current rates dur to the value increase there.
However SBTX is a animal in a completely different league. However no real income and lots of jam tomorrow prospects.
This could quickly snowball into a serious earner as long as the transition from study results to income stream is transparent and swift. In this can be achieved and demonstrated, prices could easily be 3 figs before autumn, just in time for the "beauty parade" which will really set things alight.

well I also hold opti in a 6:4 split , and I wouldn't be surprised to see the next major move north in OPTI. As this value grows it imparts more value to OPTI, so much so I'm actually considering my next purchase might be there.
Know most investors here also have a foot in both stocks, and believe both have great merits.

yes fully study completion is 14 days later after treatment finished, which will be 27th, however treatment over in 5 days for the first starters.

Welcome prudent fox, good to see new investors. only 5 days to go now until the first participants finish all their treatment. then its just monitoring for 14 days, to gauge timeline of re onset of condition.

Must be darn close to clear blue all time high.
on the 57p resistance point, which I doubt will be strong. Already upward pressure without todays news.

"powerful effects of the microbiome on skin health". Where have we already heard that those o the study are also seeing improvements in overall complexion.... Knew the company would see the massive significance here, and are clearly acting already. Potentially not just sun cream, and it was news to me that some of the nasties from suncream enter your bloodstream.
But a new treatment for everyone to improve skin health. Great RNS, also shows a rapidly developing and expanding pipeline. Clearly in the message they have already seen the strong possibility that they have something else as well.

sbtx current price is built on what the company might do, Mr. Market is fickle and one bad result and the price will crash . Opti's is undervalued currently but based o solid income from multiple worldwide partners. Much more robust.

Thats the third resistance point now breached. Listed top 1% buy by barchart.
https://www.barchart.com/stocks/quotes/SBTX.LN/overview

Those iii's selling last week were only balancing the books at the end of the tax year. Seems like its now stopped being a new year, so the suppression on the share price has ceased, and its free to fly again.
Clearly the price is starting to respond already to that one way pressure.

yes agree Ghost,
Can also add that some of those who didnt initially have any reaction at all to the treatment and classed as acute sufferers when those first shots were shared , started to show signs of improvement later on.
7 days and the first participants have finished taking the treatment.
Well I've nothing for sale.